chr15-48793359-T-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001194998.2(CEP152):āc.794A>Cā(p.Gln265Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000889 in 1,461,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000089 ( 0 hom. )
Consequence
CEP152
NM_001194998.2 missense
NM_001194998.2 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 6.24
Genes affected
CEP152 (HGNC:29298): (centrosomal protein 152) This gene encodes a protein that is thought to be involved with centrosome function. Mutations in this gene have been associated with primary microcephaly (MCPH4). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.845
PP5
Variant 15-48793359-T-G is Pathogenic according to our data. Variant chr15-48793359-T-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 55.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-48793359-T-G is described in Lovd as [Pathogenic]. Variant chr15-48793359-T-G is described in Lovd as [Likely_benign].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP152 | NM_001194998.2 | c.794A>C | p.Gln265Pro | missense_variant | 7/27 | ENST00000380950.7 | NP_001181927.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP152 | ENST00000380950.7 | c.794A>C | p.Gln265Pro | missense_variant | 7/27 | 1 | NM_001194998.2 | ENSP00000370337.2 | ||
CEP152 | ENST00000399334.7 | c.794A>C | p.Gln265Pro | missense_variant | 7/26 | 1 | ENSP00000382271.3 | |||
CEP152 | ENST00000325747.9 | c.515A>C | p.Gln172Pro | missense_variant | 6/25 | 1 | ENSP00000321000.5 | |||
CEP152 | ENST00000560322.5 | n.794A>C | non_coding_transcript_exon_variant | 7/13 | 1 | ENSP00000453440.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249462Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135360
GnomAD3 exomes
AF:
AC:
3
AN:
249462
Hom.:
AF XY:
AC XY:
1
AN XY:
135360
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461714Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727170
GnomAD4 exome
AF:
AC:
13
AN:
1461714
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Microcephaly 9, primary, autosomal recessive Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 24, 2014 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 09, 2010 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 03, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CEP152 protein function. ClinVar contains an entry for this variant (Variation ID: 55). This missense change has been observed in individual(s) with primary microcephaly (PMID: 20598275). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs267606717, gnomAD 0.003%). This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 265 of the CEP152 protein (p.Gln265Pro). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 31, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20598275, 23456457, 21668957, 30086807) - |
CEP152-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Sep 01, 2017 | The CEP152 c.794A>C (p.Gln265Pro) missense variant has been reported in one study in which it was found in three individuals with microcephaly, with head circumferences between five and seven standard deviations below the mean, including in two individuals in a homozygous state and in one individual in a compound heterozygous state with a null variant on the second allele (Guernsey et al. 2010). The p.Gln265Pro variant was found in a heterozygous state in each of the unaffected parents of the affected individuals. The p.Gln265Pro variant was absent from 496 control chromosomes including 310 local Maritime control chromosomes and 186 European control chromosomes from the Centre d'Etude du Polymorphisme Humain (CEPH) (Guernsey et al. 2010). The variant is reported at a frequency of 0.000027 in the European (non-Finnish) population of the Genome Aggregation Database. Transfection of the variant protein into human U2OS osteosarcoma-derived cells did not affect localization, with the variant protein being found in the centrosomes similarly to wild type. However, the Gln265 residue is highly conserved among vertebrates and is predicted to fall in a coiled-coiled region predicted to be disrupted by substitution of a proline residue (Guernsey et al. 2010). Based on the evidence, the c.794A>C (p.Gln265Pro) variant is classified as likely pathogenic for CEP152-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Seckel syndrome 5;C3553886:Microcephaly 9, primary, autosomal recessive Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;.;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at